AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

Fintel reports that on July 16, 2025, Lake Street initiated coverage of AngioDynamics (NasdaqGS:ANGO) with a Buy ...

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q4 2025 earnings on Jul 15, 2025. The consensus estimate for Q4 2025 ...

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

In the latest market close, AngioDynamics (ANGO) reached $6.09, with a -0.98% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.57% for the ...

Medical technology company AngioDynamics Inc is bucking what it calls an "extraordinary" effort by a rival company to recover hundreds of thousands of dollars in legal costs following its win at ...

QUEENSBURY -- Queensbury-based medical device manufacturer AngioDynamics Inc. said Tuesday afternoon it expects to be in its new headquarters building in Latham by early spring. The company ...

AngioDynamics, Inc. ANGO reported an adjusted earnings per share (EPS) of 3 cents for third-quarter fiscal 2025, narrower than the year-ago quarter’s adjusted loss per share of 16 cents and the ...